EFTA01519051.pdf

GHISLAINE MAXWELL -TAP DYS ACCT. For the Period 1011/13 to 10/31/13 Quantity/Original Cost/Net Capital Called Net Distributions Estimated Est. Annual Inc. Commitment Amount Since Inception Since Inception Value Accrued Div. Yield Real Estate a Infrastructure TORTOISE MLP 8 PIPELINE-INS 2,296.77 30,616.00 35,094.71 204.41 0.58% 56166Y-40.4 TORI X Total Real Estate B Infrastructure $60,707.00 $0.00 06,866.71 $639.84 Amounts shown above under "Estimated Value" for private equity funds are estimates based on the latest fund values received from each underlying fund, which value may be as of a date (underlying fund value date) prior to the period covered by this statement. The values provided by the underlying fund have been adjusted for any cash flows between your account and such fund that have occurred subsequent to the underlying fund value date to derive the "Estimated Value". Therefore, such "Estimated Value" may not reflect the value of your interest shown on any fund's actual books and records as of the date of this statement. For additional information, please contact your J.P. Morgan representative. For private equity funds, Estimated Values are based on estimates provided by the underlying funds that are generally presented on a US GAAP basis, which records investments at fair value, or "marked-to-marker. Most of these underlying funds also present their audited financial statements on a US GAAP basis (i.e.. "marked-to-market"). However, some of these underlying funds present their audited financial statements using the Income Tax Basis of Accounting, which records investments 'at cost based on the accrual basis of accounting for Federal income taxes. Where the underlying fund provides periodic estimates on a 'marked-to-marker basis but reflects investments "at cost" in its audited financial statements, the marked-to-market Estimated Value shown herein for a private equity fund may be materially different from the value reflected on such fund's audited financial statements (which are also based on the audited financial statements of the underlying fund). J.P. Morgan Acciour Page 8 of 15 Consolidated Statement Page 59 Confidential Treatment Requested by JPMorgan JPM-SDNY-00046319 Chase CONFIDENTIAL SDNY_GM_00315517 EFTA01519051